Invesaro

Stocks AMAL Financial statements

Financial statements

Amalgamated Financial Corp. financial statements

Income statement, balance sheet and cash flow statement for the last 8 fiscal years, taken from the XBRL data Amalgamated Financial Corp. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2018FY2020FY2020FY2021FY2022FY2023FY2024FY2025
Selling and marketing3.42.913.513.233.744.183.732.35
Interest expense14.219.310.56.2218.696.8
Pre-tax income50.364.261.970.7108125146140
Income tax5.671715.817.826.736.839.235.7
Net income to minority interests000
Net income44.747.246.252.981.588106104
EPS, basic1.471.491.481.702.642.883.483.44
EPS, diluted1.461.471.481.682.612.863.443.41
Shares, basic (weighted)30.431.731.131.130.830.630.630.3
Shares, diluted (weighted)30.632.231.231.531.230.830.930.6
Dividend per share0.060.260.320.32

Balance sheet

FY2018FY2020FY2020FY2021FY2022FY2023FY2024FY2025
Cash and equivalents80.812338.833063.590.660.7291
Property, plant and equipment17.81311.79.867.816.394.69
Lease right-of-use assets47.336.133.128.221.114.29.6
Goodwill12.912.912.912.912.912.912.9
Intangible assets5.364.153.112.21.50.9
Total assets5,3255,9797,0787,8437,9728,2578,870
Total liabilities4,8355,4436,5147,3347,3877,5498,075
Total debt750
Paid-in capital306301298287288289294
Retained earnings181217260330388480567
Treasury stock0-5.34-2.82-35.2
Other comprehensive income3.2317.25.41-109-86-58.6-32.1
Shareholders' equity490536564509585708
Minority interests0.130.130.130.130.130
Total equity439491536564509585708794
Total liabilities and equity5,3255,9797,0787,8437,9728,2578,870
Shares outstanding31.53131.130.730.430.729.8

Cash flow statement

FY2018FY2020FY2020FY2021FY2022FY2023FY2024FY2025
Net income44.747.246.252.981.588106104
Depreciation and amortization4.24.636.193.649.35.514.76.22
Stock-based compensation0.922.442.391.82.684.695.536.92
Deferred income tax4.665.03-0.417.0514.44.245.181.68
Cash from operations3183.565.870.5147117124136
Capital expenditures-1.43-0.75-1.61-2.4-1.67-1.48-1.78-1.38
Acquisitions31.700
Purchases of investments-595-479-684-1,221-679-116-825-965
Sales and maturities of investments250206279508326168311478
Cash from investing-258-546-755-865-1,202-134-316-378
Stock issued00000.670.80.791.39
Share buybacks0-5.79-7-2.92-12.5-8.32-1.13-32.3
Dividends paid-1.93-8.3-9.99-9.98-11.2-12.3-14.2-17.2
Cash from financing1925046061,08778844.2162473
Net change in cash-35.641.7-83.8292-26727-29.8230
Free cash flow29.682.764.268.1146116122134
Interest paid14.61911.56.041885.7129124
Income taxes paid3.569.319.825.696.6522.63420

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $47.58 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Effective tax rate24.7%Income tax / pre-tax income, when pre-tax income is positive.
Return on assets (ROA)1.2%Net income / average total assets.

Growth

MetricValueHow it is calculated
Net income growth, 1y-1.9%Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y8.6%Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y17.7%Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y-0.9%EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y9.3%Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y18.2%Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y9.4%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y-2.7%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y15.6%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y9.9%Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y-2.6%Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y15.9%Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y7.4%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y4.2%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y8.2%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y-1.0%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y-0.6%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y-0.4%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Liabilities / assets91.1%Total liabilities / total assets.
Goodwill and intangibles / assets0.1%(Goodwill + intangible assets) / total assets.

Efficiency

MetricValueHow it is calculated
FCF conversion129.3%Free cash flow / net income, when net income is positive.
Capex / operating cash flow10.5%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted$3.76Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
FCF per share$4.86Free cash flow / diluted weighted shares.
Operating cash flow per share$5.43Cash from operations / diluted weighted shares.
Cash per share$5.61(Cash + short-term investments) / shares outstanding.
Payout ratio16.6%Dividends paid / net income, when net income is positive.
Dividends / FCF12.8%Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF15.0%Share buybacks / free cash flow, when free cash flow is positive.

Valuation

MetricValueHow it is calculated
Market cap$1.42BShare price x shares outstanding.
Enterprise value$1.25BMarket cap + total debt - cash - short-term investments.
P/E12.5xMarket cap / net income. Only when net income is positive.
P/FCF9.70xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF8.68xMarket cap / cash from operations, when positive.
EV/FCF8.56xEnterprise value / free cash flow, when both are positive.
FCF yield10.3%Free cash flow / market cap.
Earnings yield8.0%Net income / market cap (the inverse of P/E).
Dividend yield1.3%Dividends paid over the period / market cap.
Shareholder yield2.9%(Dividends paid + share buybacks) / market cap.
PEG1.35xP/E / EPS growth per year over 3 years (in percent). Only when both are positive.
Was Amalgamated Financial Corp. profitable in fiscal 2025?

Yes. Net income was $104.4M, a net margin of -.

How much free cash flow did Amalgamated Financial Corp. generate in fiscal 2025?

Cash from operations of $135.8M minus capital expenditures of $1.4M left free cash flow of $134.4M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Amalgamated Financial Corp.